Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aravind Ramakrishnan

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Expert Review of Hematology|April 13, 2010
Optimizing reduced-intensity conditioning regimens for myeloproliferative neoplasmsAravind Ramakrishnan, Brenda M Sandmaier
Expert Opinion on Biological Therapy|December 10, 2008
A novel role for the marrow microenvironment in initiating and sustaining hematopoietic diseaseAravind Ramakrishnan, H Joachim Deeg
Cellular Therapy and Transplantation|January 19, 2011
The role of the marrow microenvironment in hematopoietic stem cell transplantationAravind Ramakrishnan, Beverly J Torok-Storb
Methods in Molecular Biology (Clifton, N.J.)|August 21, 2013
Primary marrow-derived stromal cells: isolation and manipulationAravind Ramakrishnan, Beverly Torok-Storb, Manoj M Pillai
Current Cancer Therapy Reviews|March 23, 2010
Myeloid Malignancies and the Marrow Microenvironment: Some Recent Studies in Patients with MDSA Mario Marcondes, Aravind Ramakrishnan, H Joachim Deeg
Biochemical and Biophysical Research Communications|August 16, 2005
Regulation of Bcl-3 through interaction with the Lck tyrosine kinaseYujie Zhao, Aravind Ramakrishnan, Kyoung-Eun Kim, et al.
Hematology/Oncology and Stem Cell Therapy|December 20, 2022
Adoptive Cellular Therapy in Acute Myeloid Leukemia: Current Scope and ChallengesSankalp Arora, Palash Asawa, Aravind Ramakrishnan, et al.
Drug Metabolism and Personalized Therapy|July 13, 2016
Medication therapy management (MTM): an innovative approach to improve medication adherence in diabeticsAthira Bindu Murali, Belsy Boban, Aswathy Karoor Shanmughan, et al.
British Journal of Haematology|March 25, 2010
Anti-thymocyte globulin plus etanercept as therapy for myelodysplastic syndromes (MDS): a phase II studyBart L Scott, Aravind Ramakrishnan, Mark Fosdal, et al.
Blood|September 7, 2006
Reduced expression of inducible gelatinase B/matrix metalloproteinase-9 in monocytes from patients with myelodysplastic syndrome: Correlation of inducible levels with the percentage of cytogenetically marked cells and with marrow cellularityMineo Iwata, Manoj Pillai, Aravind Ramakrishnan, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Expert Review of Hematology|April 13, 2010
Optimizing reduced-intensity conditioning regimens for myeloproliferative neoplasmsAravind Ramakrishnan, Brenda M Sandmaier
Expert Opinion on Biological Therapy|December 10, 2008
A novel role for the marrow microenvironment in initiating and sustaining hematopoietic diseaseAravind Ramakrishnan, H Joachim Deeg
Cellular Therapy and Transplantation|January 19, 2011
The role of the marrow microenvironment in hematopoietic stem cell transplantationAravind Ramakrishnan, Beverly J Torok-Storb
Methods in Molecular Biology (Clifton, N.J.)|August 21, 2013
Primary marrow-derived stromal cells: isolation and manipulationAravind Ramakrishnan, Beverly Torok-Storb, Manoj M Pillai
Current Cancer Therapy Reviews|March 23, 2010
Myeloid Malignancies and the Marrow Microenvironment: Some Recent Studies in Patients with MDSA Mario Marcondes, Aravind Ramakrishnan, H Joachim Deeg
Biochemical and Biophysical Research Communications|August 16, 2005
Regulation of Bcl-3 through interaction with the Lck tyrosine kinaseYujie Zhao, Aravind Ramakrishnan, Kyoung-Eun Kim, et al.
Hematology/Oncology and Stem Cell Therapy|December 20, 2022
Adoptive Cellular Therapy in Acute Myeloid Leukemia: Current Scope and ChallengesSankalp Arora, Palash Asawa, Aravind Ramakrishnan, et al.
Drug Metabolism and Personalized Therapy|July 13, 2016
Medication therapy management (MTM): an innovative approach to improve medication adherence in diabeticsAthira Bindu Murali, Belsy Boban, Aswathy Karoor Shanmughan, et al.
British Journal of Haematology|March 25, 2010
Anti-thymocyte globulin plus etanercept as therapy for myelodysplastic syndromes (MDS): a phase II studyBart L Scott, Aravind Ramakrishnan, Mark Fosdal, et al.
Blood|September 7, 2006
Reduced expression of inducible gelatinase B/matrix metalloproteinase-9 in monocytes from patients with myelodysplastic syndrome: Correlation of inducible levels with the percentage of cytogenetically marked cells and with marrow cellularityMineo Iwata, Manoj Pillai, Aravind Ramakrishnan, et al.
Pageof 4